Literature DB >> 26861166

Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.

Sara L Van Driest1,2, Matthew D Marshall3, Brian Hachey4, Cole Beck5, Kim Crum1, Jill Owen1, Andrew H Smith1, Prince J Kannankeril1, Alison Woodworth6, Richard M Caprioli4, Leena Choi5.   

Abstract

AIMS: One barrier contributing to the lack of pharmacokinetic (PK) data in paediatric populations is the need for serial sampling. Analysis of clinically obtained specimens and data may overcome this barrier. To add evidence for the feasibility of this approach, we sought to determine PK parameters for fentanyl in children after cardiac surgery using specimens and data generated in the course of clinical care, without collecting additional blood samples.
METHODS: We measured fentanyl concentrations in plasma from leftover clinically-obtained specimens in 130 paediatric cardiac surgery patients and successfully generated a PK dataset using drug dosing data extracted from electronic medical records. Using a population PK approach, we estimated PK parameters for this population, assessed model goodness-of-fit and internal model validation, and performed subset data analyses. Through simulation studies, we compared predicted fentanyl concentrations using model-driven weight-adjusted per kg vs. fixed per kg fentanyl dosing.
RESULTS: Fentanyl clearance for a 6.4 kg child, the median weight in our cohort, is 5.7 l h(-1) (2.2-9.2 l h(-1) ), similar to values found in prior formal PK studies. Model assessment and subset analyses indicated the model adequately fit the data. Of the covariates studied, only weight significantly impacted fentanyl kinetics, but substantial inter-individual variability remained. In simulation studies, model-driven weight-adjusted per kg fentanyl dosing led to more consistent therapeutic fentanyl concentrations than fixed per kg dosing.
CONCLUSIONS: We show here that population PK modelling using sparse remnant samples and electronic medical records data provides a powerful tool for assessment of drug kinetics and generation of individualized dosing regimens.
© 2016 The British Pharmacological Society.

Entities:  

Keywords:  analgesia; opportunistic research; paediatrics; population pharmacokinetics; post-operative pain; pragmatic research

Mesh:

Substances:

Year:  2016        PMID: 26861166      PMCID: PMC4876191          DOI: 10.1111/bcp.12903

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  The minimum effective concentration of opioids: a revisitation with patient controlled analgesia fentanyl.

Authors:  A Woodhouse; L E Mather
Journal:  Reg Anesth Pain Med       Date:  2000 May-Jun       Impact factor: 6.288

2.  Commentary on significance levels for covariate effects in NONMEM.

Authors:  Stuart L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

3.  Fentanyl-induced ventilatory depression: effects of age.

Authors:  R E Hertzka; I S Gauntlett; D M Fisher; M J Spellman
Journal:  Anesthesiology       Date:  1989-02       Impact factor: 7.892

4.  Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age.

Authors:  I S Gauntlett; D M Fisher; R E Hertzka; E Kuhls; M J Spellman; C Rudolph
Journal:  Anesthesiology       Date:  1988-11       Impact factor: 7.892

5.  Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.

Authors:  Wei Zhao; Daolun Zhang; Thomas Storme; André Baruchel; Xavier Declèves; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2015-09-05       Impact factor: 4.335

6.  The pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia.

Authors:  Melissa Wheeler; Patrick K Birmingham; Ralph A Lugo; Corri L Heffner; Charles J Coté
Journal:  Anesth Analg       Date:  2004-11       Impact factor: 5.108

7.  Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery.

Authors:  G Koren; G Goresky; P Crean; J Klein; S M MacLeod
Journal:  Anesth Analg       Date:  1984-06       Impact factor: 5.108

8.  Plasma concentrations of fentanyl in infants, children and adults.

Authors:  M A Singleton; J I Rosen; D M Fisher
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

9.  Pharmacokinetics of fentanyl in neonates.

Authors:  D E Koehntop; J H Rodman; D M Brundage; M G Hegland; J J Buckley
Journal:  Anesth Analg       Date:  1986-03       Impact factor: 5.108

10.  Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Authors:  D Gonzalez; C Melloni; R Yogev; B B Poindexter; S R Mendley; P Delmore; J E Sullivan; J Autmizguine; A Lewandowski; B Harper; K M Watt; K C Lewis; E V Capparelli; D K Benjamin; M Cohen-Wolkowiez
Journal:  Clin Pharmacol Ther       Date:  2014-06-20       Impact factor: 6.903

View more
  13 in total

1.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.

Authors:  Fanuel T Hagos; Christopher M Horvat; Alicia K Au; Yvette P Conley; Lingjue Li; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

3.  Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.

Authors:  Sara L Van Driest; Matthew D Marshall; Brian Hachey; Cole Beck; Kim Crum; Jill Owen; Andrew H Smith; Prince J Kannankeril; Alison Woodworth; Richard M Caprioli; Leena Choi
Journal:  Br J Clin Pharmacol       Date:  2016-04-15       Impact factor: 4.335

Review 4.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

Review 5.  Integrating real-world data to accelerate and guide drug development: A clinical pharmacology perspective.

Authors:  Xiaochen Zhao; Shahed Iqbal; Ivelisse L Valdes; Mark Dresser; Sandhya Girish
Journal:  Clin Transl Sci       Date:  2022-08-07       Impact factor: 4.438

6.  Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?

Authors:  Sara L Van Driest; Leena Choi
Journal:  Clin Pharmacol Ther       Date:  2019-04-03       Impact factor: 6.875

Review 7.  Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.

Authors:  Dan M Roden; Sara L Van Driest; Quinn S Wells; Jonathan D Mosley; Joshua C Denny; Josh F Peterson
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

8.  Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children.

Authors:  Sebastiaan C Goulooze; Erwin Ista; Monique van Dijk; Dick Tibboel; Elke H J Krekels; Catherijne A J Knibbe
Journal:  AAPS J       Date:  2021-05-17       Impact factor: 4.009

9.  Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis.

Authors:  Anil R Maharaj; Huali Wu; Kanecia O Zimmerman; David G Speicher; Janice E Sullivan; Kevin Watt; Amira Al-Uzri; Elizabeth H Payne; Jinson Erinjeri; Susan Lin; Barrie Harper; Chiara Melloni; Christoph P Hornik
Journal:  J Clin Pharmacol       Date:  2019-12-08       Impact factor: 2.860

10.  Development of a System for Postmarketing Population Pharmacokinetic and Pharmacodynamic Studies Using Real-World Data From Electronic Health Records.

Authors:  Leena Choi; Cole Beck; Elizabeth McNeer; Hannah L Weeks; Michael L Williams; Nathan T James; Xinnan Niu; Bassel W Abou-Khalil; Kelly A Birdwell; Dan M Roden; C Michael Stein; Cosmin A Bejan; Joshua C Denny; Sara L Van Driest
Journal:  Clin Pharmacol Ther       Date:  2020-02-11       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.